Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,367
archived clinical trials in
High Blood Pressure (Hypertension)

Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Status: Enrolling
Updated:  12/31/1969
University of Cincinnati Pulmonary Critical Care & Sleep Medicine
mi
from
Cincinnati, OH
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Status: Enrolling
Updated: 12/31/1969
University of Cincinnati Pulmonary Critical Care & Sleep Medicine
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Status: Enrolling
Updated:  12/31/1969
Cleveland Clinic
mi
from
Cleveland, OH
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Status: Enrolling
Updated:  12/31/1969
Dayton Respiratory Center
mi
from
Dayton, OH
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Status: Enrolling
Updated: 12/31/1969
Dayton Respiratory Center
mi
from
Dayton, OH
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Status: Enrolling
Updated:  12/31/1969
University of Toledo Health Sciences Campus
mi
from
Toledo, OH
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Status: Enrolling
Updated: 12/31/1969
University of Toledo Health Sciences Campus
mi
from
Toledo, OH
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Status: Enrolling
Updated:  12/31/1969
Heart Center Cardiology
mi
from
Bend, OR
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Status: Enrolling
Updated: 12/31/1969
Heart Center Cardiology
mi
from
Bend, OR
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Status: Enrolling
Updated:  12/31/1969
Central Bucks Specialists - The Pavilion at Doylestown Hospital
mi
from
Doylestown, PA
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Status: Enrolling
Updated: 12/31/1969
Central Bucks Specialists - The Pavilion at Doylestown Hospital
mi
from
Doylestown, PA
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Status: Enrolling
Updated:  12/31/1969
Institute for Respiratory and Sleep Medicine
mi
from
Langhorne, PA
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Status: Enrolling
Updated: 12/31/1969
Institute for Respiratory and Sleep Medicine
mi
from
Langhorne, PA
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Status: Enrolling
Updated:  12/31/1969
Pulmonary Hypertension Program, Cardiology, Children's Hospial of Philadelphia
mi
from
Philadelphia, PA
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Status: Enrolling
Updated: 12/31/1969
Pulmonary Hypertension Program, Cardiology, Children's Hospial of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Status: Enrolling
Updated:  12/31/1969
Pulmonary Vascular Disease Program, Penn Presbyterian Medical Center
mi
from
Philadelphia, PA
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Status: Enrolling
Updated: 12/31/1969
Pulmonary Vascular Disease Program, Penn Presbyterian Medical Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Status: Enrolling
Updated:  12/31/1969
Temple University Hospital
mi
from
Philadelphia, PA
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Status: Enrolling
Updated: 12/31/1969
Temple University Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Status: Enrolling
Updated:  12/31/1969
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Status: Enrolling
Updated: 12/31/1969
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Status: Enrolling
Updated:  12/31/1969
Wellspan Lung, Sleep and Critical Care
mi
from
York, PA
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Status: Enrolling
Updated: 12/31/1969
Wellspan Lung, Sleep and Critical Care
mi
from
York, PA
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Status: Enrolling
Updated:  12/31/1969
Rhode Island Hospital
mi
from
Providence, RI
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Status: Enrolling
Updated: 12/31/1969
Rhode Island Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Status: Enrolling
Updated:  12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Status: Enrolling
Updated: 12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Status: Enrolling
Updated:  12/31/1969
Statcare Pulmonary Consultants
mi
from
Knoxville, TN
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Status: Enrolling
Updated: 12/31/1969
Statcare Pulmonary Consultants
mi
from
Knoxville, TN
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Status: Enrolling
Updated:  12/31/1969
El Paso Respiratory and Sleep Consultants
mi
from
El Paso, TX
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Status: Enrolling
Updated: 12/31/1969
El Paso Respiratory and Sleep Consultants
mi
from
El Paso, TX
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Status: Enrolling
Updated:  12/31/1969
University of Texas Medical Branch
mi
from
Galveston, TX
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Status: Enrolling
Updated: 12/31/1969
University of Texas Medical Branch
mi
from
Galveston, TX
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Status: Enrolling
Updated:  12/31/1969
Baylor College of Medicine
mi
from
Houston, TX
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Status: Enrolling
Updated: 12/31/1969
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Status: Enrolling
Updated:  12/31/1969
UT Health - University of Texas Houston
mi
from
Houston, TX
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Status: Enrolling
Updated: 12/31/1969
UT Health - University of Texas Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Status: Enrolling
Updated:  12/31/1969
Providence Health Center
mi
from
Waco, TX
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Status: Enrolling
Updated: 12/31/1969
Providence Health Center
mi
from
Waco, TX
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Status: Enrolling
Updated:  12/31/1969
IHVI, Advanced Lung Disease and Transplant Clinic
mi
from
Falls Church, VA
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Status: Enrolling
Updated: 12/31/1969
IHVI, Advanced Lung Disease and Transplant Clinic
mi
from
Falls Church, VA
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Status: Enrolling
Updated:  12/31/1969
Sentara Medical Group
mi
from
Norfolk, VA
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Status: Enrolling
Updated: 12/31/1969
Sentara Medical Group
mi
from
Norfolk, VA
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Status: Enrolling
Updated:  12/31/1969
Cardiac Study Center
mi
from
Puyallup, WA
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Status: Enrolling
Updated: 12/31/1969
Cardiac Study Center
mi
from
Puyallup, WA
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Status: Enrolling
Updated:  12/31/1969
University Hospitals at Case Medical Center
mi
from
Cleveland, OH
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Status: Enrolling
Updated: 12/31/1969
University Hospitals at Case Medical Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Status: Enrolling
Updated:  12/31/1969
Respiratory Specialists
mi
from
Wyomissing, PA
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Status: Enrolling
Updated: 12/31/1969
Respiratory Specialists
mi
from
Wyomissing, PA
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Status: Enrolling
Updated:  12/31/1969
PAH Clinic CPR at Auxilio Mutuo
mi
from
San Juan,
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Status: Enrolling
Updated: 12/31/1969
PAH Clinic CPR at Auxilio Mutuo
mi
from
San Juan,
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Status: Enrolling
Updated:  12/31/1969
Robert E. Benkert, M.D.P.C.
mi
from
Wheat Ridge, CO
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Status: Enrolling
Updated: 12/31/1969
Robert E. Benkert, M.D.P.C.
mi
from
Wheat Ridge, CO
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Status: Enrolling
Updated:  12/31/1969
Wake Forest University Phyisicans Clinic/Pulmonary
mi
from
Winston-Salem, NC
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Status: Enrolling
Updated: 12/31/1969
Wake Forest University Phyisicans Clinic/Pulmonary
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Status: Enrolling
Updated:  12/31/1969
Sioux Falls Cardiovascular, PC
mi
from
Sioux Falls, SD
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
Status: Enrolling
Updated: 12/31/1969
Sioux Falls Cardiovascular, PC
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Titrated Disease Management for Patients With Hypertension
Randomized Trial of Titrated Disease Management for Patients With Hypertension
Status: Enrolling
Updated:  12/31/1969
Durham VA Medical Center, Durham, NC
mi
from
Durham, NC
Titrated Disease Management for Patients With Hypertension
Randomized Trial of Titrated Disease Management for Patients With Hypertension
Status: Enrolling
Updated: 12/31/1969
Durham VA Medical Center, Durham, NC
mi
from
Durham, NC
Click here to add this to my saved trials
Pharmacokinetic Effects of QTI571 on Sildenafil and Bosentan in Pulmonary Arterial Hypertension Patients
A Non-randomized, Multiple Dose, Three Treatment Period, Open-label, Single Sequence, Single Group Study to Evaluate the Pharmacokinetic Effect of Two Doses of QTI571 (Imatinib) on the Co-administered Drugs Sildenafil and Bosentan in Pulmonary Arterial Hypertension (PAH) Patients
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
Mineola, NY
Pharmacokinetic Effects of QTI571 on Sildenafil and Bosentan in Pulmonary Arterial Hypertension Patients
A Non-randomized, Multiple Dose, Three Treatment Period, Open-label, Single Sequence, Single Group Study to Evaluate the Pharmacokinetic Effect of Two Doses of QTI571 (Imatinib) on the Co-administered Drugs Sildenafil and Bosentan in Pulmonary Arterial Hypertension (PAH) Patients
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Mineola, NY
Click here to add this to my saved trials
Pharmacokinetic Effects of QTI571 on Sildenafil and Bosentan in Pulmonary Arterial Hypertension Patients
A Non-randomized, Multiple Dose, Three Treatment Period, Open-label, Single Sequence, Single Group Study to Evaluate the Pharmacokinetic Effect of Two Doses of QTI571 (Imatinib) on the Co-administered Drugs Sildenafil and Bosentan in Pulmonary Arterial Hypertension (PAH) Patients
Status: Enrolling
Updated:  12/31/1969
Novartis Investigational Site
mi
from
Tampa, FL
Pharmacokinetic Effects of QTI571 on Sildenafil and Bosentan in Pulmonary Arterial Hypertension Patients
A Non-randomized, Multiple Dose, Three Treatment Period, Open-label, Single Sequence, Single Group Study to Evaluate the Pharmacokinetic Effect of Two Doses of QTI571 (Imatinib) on the Co-administered Drugs Sildenafil and Bosentan in Pulmonary Arterial Hypertension (PAH) Patients
Status: Enrolling
Updated: 12/31/1969
Novartis Investigational Site
mi
from
Tampa, FL
Click here to add this to my saved trials
Pharmacokinetic Effects of QTI571 on Sildenafil and Bosentan in Pulmonary Arterial Hypertension Patients
A Non-randomized, Multiple Dose, Three Treatment Period, Open-label, Single Sequence, Single Group Study to Evaluate the Pharmacokinetic Effect of Two Doses of QTI571 (Imatinib) on the Co-administered Drugs Sildenafil and Bosentan in Pulmonary Arterial Hypertension (PAH) Patients
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
Weston, FL
Pharmacokinetic Effects of QTI571 on Sildenafil and Bosentan in Pulmonary Arterial Hypertension Patients
A Non-randomized, Multiple Dose, Three Treatment Period, Open-label, Single Sequence, Single Group Study to Evaluate the Pharmacokinetic Effect of Two Doses of QTI571 (Imatinib) on the Co-administered Drugs Sildenafil and Bosentan in Pulmonary Arterial Hypertension (PAH) Patients
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Weston, FL
Click here to add this to my saved trials
Pharmacokinetic Effects of QTI571 on Sildenafil and Bosentan in Pulmonary Arterial Hypertension Patients
A Non-randomized, Multiple Dose, Three Treatment Period, Open-label, Single Sequence, Single Group Study to Evaluate the Pharmacokinetic Effect of Two Doses of QTI571 (Imatinib) on the Co-administered Drugs Sildenafil and Bosentan in Pulmonary Arterial Hypertension (PAH) Patients
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
Darlinghurst,
Pharmacokinetic Effects of QTI571 on Sildenafil and Bosentan in Pulmonary Arterial Hypertension Patients
A Non-randomized, Multiple Dose, Three Treatment Period, Open-label, Single Sequence, Single Group Study to Evaluate the Pharmacokinetic Effect of Two Doses of QTI571 (Imatinib) on the Co-administered Drugs Sildenafil and Bosentan in Pulmonary Arterial Hypertension (PAH) Patients
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Darlinghurst,
Click here to add this to my saved trials
Nebivolol and the Endothelin (ET)-1 System
Nebivolol and the Endothelin (ET)-1 System
Status: Enrolling
Updated:  12/31/1969
UC-Boulder Clinical and Translational Research Center
mi
from
Boulder, CO
Nebivolol and the Endothelin (ET)-1 System
Nebivolol and the Endothelin (ET)-1 System
Status: Enrolling
Updated: 12/31/1969
UC-Boulder Clinical and Translational Research Center
mi
from
Boulder, CO
Click here to add this to my saved trials
Study of Sildenafil to Treat Newborns With Persistent Pulmonary Hypertension
Phase II Trial of Sildenafil in Newborns With Persistent Pulmonary Hypertension
Status: Enrolling
Updated:  12/31/1969
Northwestern Memorial Hospital
mi
from
Chicago, IL
Study of Sildenafil to Treat Newborns With Persistent Pulmonary Hypertension
Phase II Trial of Sildenafil in Newborns With Persistent Pulmonary Hypertension
Status: Enrolling
Updated: 12/31/1969
Northwestern Memorial Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
Study of Sildenafil to Treat Newborns With Persistent Pulmonary Hypertension
Phase II Trial of Sildenafil in Newborns With Persistent Pulmonary Hypertension
Status: Enrolling
Updated:  12/31/1969
Primary Children's Medical Center, Utah
mi
from
Salt Lake City, UT
Study of Sildenafil to Treat Newborns With Persistent Pulmonary Hypertension
Phase II Trial of Sildenafil in Newborns With Persistent Pulmonary Hypertension
Status: Enrolling
Updated: 12/31/1969
Primary Children's Medical Center, Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Study of Sildenafil to Treat Newborns With Persistent Pulmonary Hypertension
Phase II Trial of Sildenafil in Newborns With Persistent Pulmonary Hypertension
Status: Enrolling
Updated:  12/31/1969
University of Colorado Health Sciences Ctr.
mi
from
Aurora, CO
Study of Sildenafil to Treat Newborns With Persistent Pulmonary Hypertension
Phase II Trial of Sildenafil in Newborns With Persistent Pulmonary Hypertension
Status: Enrolling
Updated: 12/31/1969
University of Colorado Health Sciences Ctr.
mi
from
Aurora, CO
Click here to add this to my saved trials
Study of Sildenafil to Treat Newborns With Persistent Pulmonary Hypertension
Phase II Trial of Sildenafil in Newborns With Persistent Pulmonary Hypertension
Status: Enrolling
Updated:  12/31/1969
University of Utah
mi
from
Salt Lake City, UT
Study of Sildenafil to Treat Newborns With Persistent Pulmonary Hypertension
Phase II Trial of Sildenafil in Newborns With Persistent Pulmonary Hypertension
Status: Enrolling
Updated: 12/31/1969
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Study of Sildenafil to Treat Newborns With Persistent Pulmonary Hypertension
Phase II Trial of Sildenafil in Newborns With Persistent Pulmonary Hypertension
Status: Enrolling
Updated:  12/31/1969
Vanderbilt University
mi
from
Nashville, TN
Study of Sildenafil to Treat Newborns With Persistent Pulmonary Hypertension
Phase II Trial of Sildenafil in Newborns With Persistent Pulmonary Hypertension
Status: Enrolling
Updated: 12/31/1969
Vanderbilt University
mi
from
Nashville, TN
Click here to add this to my saved trials
Study of Sildenafil to Treat Newborns With Persistent Pulmonary Hypertension
Phase II Trial of Sildenafil in Newborns With Persistent Pulmonary Hypertension
Status: Enrolling
Updated:  12/31/1969
Women's & Children's Hospital of Buffalo SUNY
mi
from
Buffalo, NY
Study of Sildenafil to Treat Newborns With Persistent Pulmonary Hypertension
Phase II Trial of Sildenafil in Newborns With Persistent Pulmonary Hypertension
Status: Enrolling
Updated: 12/31/1969
Women's & Children's Hospital of Buffalo SUNY
mi
from
Buffalo, NY
Click here to add this to my saved trials
Study of Sildenafil to Treat Newborns With Persistent Pulmonary Hypertension
Phase II Trial of Sildenafil in Newborns With Persistent Pulmonary Hypertension
Status: Enrolling
Updated:  12/31/1969
Anne & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Study of Sildenafil to Treat Newborns With Persistent Pulmonary Hypertension
Phase II Trial of Sildenafil in Newborns With Persistent Pulmonary Hypertension
Status: Enrolling
Updated: 12/31/1969
Anne & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
52-104 Week Off-therapy Second Extension to Study CSPP100A2365
A Multicenter, Double-blind 52 to 104 Week Off-therapy Extension Study to Evaluate the Long Term Growth and Development of Pediatric Hypertensive Patients 6 - 17 Years of Age Previously Treated With Aliskiren in Studies CSPP100A2365 and/or CSPP100A2365E1
Status: Enrolling
Updated:  12/31/1969
Novartis Investigator Site
mi
from
Birmingham, AL
52-104 Week Off-therapy Second Extension to Study CSPP100A2365
A Multicenter, Double-blind 52 to 104 Week Off-therapy Extension Study to Evaluate the Long Term Growth and Development of Pediatric Hypertensive Patients 6 - 17 Years of Age Previously Treated With Aliskiren in Studies CSPP100A2365 and/or CSPP100A2365E1
Status: Enrolling
Updated: 12/31/1969
Novartis Investigator Site
mi
from
Birmingham, AL
Click here to add this to my saved trials
52-104 Week Off-therapy Second Extension to Study CSPP100A2365
A Multicenter, Double-blind 52 to 104 Week Off-therapy Extension Study to Evaluate the Long Term Growth and Development of Pediatric Hypertensive Patients 6 - 17 Years of Age Previously Treated With Aliskiren in Studies CSPP100A2365 and/or CSPP100A2365E1
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
Little Rock, AR
52-104 Week Off-therapy Second Extension to Study CSPP100A2365
A Multicenter, Double-blind 52 to 104 Week Off-therapy Extension Study to Evaluate the Long Term Growth and Development of Pediatric Hypertensive Patients 6 - 17 Years of Age Previously Treated With Aliskiren in Studies CSPP100A2365 and/or CSPP100A2365E1
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Little Rock, AR
Click here to add this to my saved trials
52-104 Week Off-therapy Second Extension to Study CSPP100A2365
A Multicenter, Double-blind 52 to 104 Week Off-therapy Extension Study to Evaluate the Long Term Growth and Development of Pediatric Hypertensive Patients 6 - 17 Years of Age Previously Treated With Aliskiren in Studies CSPP100A2365 and/or CSPP100A2365E1
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
Dalton, GA
52-104 Week Off-therapy Second Extension to Study CSPP100A2365
A Multicenter, Double-blind 52 to 104 Week Off-therapy Extension Study to Evaluate the Long Term Growth and Development of Pediatric Hypertensive Patients 6 - 17 Years of Age Previously Treated With Aliskiren in Studies CSPP100A2365 and/or CSPP100A2365E1
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Dalton, GA
Click here to add this to my saved trials
52-104 Week Off-therapy Second Extension to Study CSPP100A2365
A Multicenter, Double-blind 52 to 104 Week Off-therapy Extension Study to Evaluate the Long Term Growth and Development of Pediatric Hypertensive Patients 6 - 17 Years of Age Previously Treated With Aliskiren in Studies CSPP100A2365 and/or CSPP100A2365E1
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
Lewiston, ID
52-104 Week Off-therapy Second Extension to Study CSPP100A2365
A Multicenter, Double-blind 52 to 104 Week Off-therapy Extension Study to Evaluate the Long Term Growth and Development of Pediatric Hypertensive Patients 6 - 17 Years of Age Previously Treated With Aliskiren in Studies CSPP100A2365 and/or CSPP100A2365E1
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Lewiston, ID
Click here to add this to my saved trials
52-104 Week Off-therapy Second Extension to Study CSPP100A2365
A Multicenter, Double-blind 52 to 104 Week Off-therapy Extension Study to Evaluate the Long Term Growth and Development of Pediatric Hypertensive Patients 6 - 17 Years of Age Previously Treated With Aliskiren in Studies CSPP100A2365 and/or CSPP100A2365E1
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
Hattiesburg, MS
52-104 Week Off-therapy Second Extension to Study CSPP100A2365
A Multicenter, Double-blind 52 to 104 Week Off-therapy Extension Study to Evaluate the Long Term Growth and Development of Pediatric Hypertensive Patients 6 - 17 Years of Age Previously Treated With Aliskiren in Studies CSPP100A2365 and/or CSPP100A2365E1
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Hattiesburg, MS
Click here to add this to my saved trials
52-104 Week Off-therapy Second Extension to Study CSPP100A2365
A Multicenter, Double-blind 52 to 104 Week Off-therapy Extension Study to Evaluate the Long Term Growth and Development of Pediatric Hypertensive Patients 6 - 17 Years of Age Previously Treated With Aliskiren in Studies CSPP100A2365 and/or CSPP100A2365E1
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
Jackson, MS
52-104 Week Off-therapy Second Extension to Study CSPP100A2365
A Multicenter, Double-blind 52 to 104 Week Off-therapy Extension Study to Evaluate the Long Term Growth and Development of Pediatric Hypertensive Patients 6 - 17 Years of Age Previously Treated With Aliskiren in Studies CSPP100A2365 and/or CSPP100A2365E1
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Jackson, MS
Click here to add this to my saved trials
52-104 Week Off-therapy Second Extension to Study CSPP100A2365
A Multicenter, Double-blind 52 to 104 Week Off-therapy Extension Study to Evaluate the Long Term Growth and Development of Pediatric Hypertensive Patients 6 - 17 Years of Age Previously Treated With Aliskiren in Studies CSPP100A2365 and/or CSPP100A2365E1
Status: Enrolling
Updated:  12/31/1969
Novartis
mi
from
New York, NY
52-104 Week Off-therapy Second Extension to Study CSPP100A2365
A Multicenter, Double-blind 52 to 104 Week Off-therapy Extension Study to Evaluate the Long Term Growth and Development of Pediatric Hypertensive Patients 6 - 17 Years of Age Previously Treated With Aliskiren in Studies CSPP100A2365 and/or CSPP100A2365E1
Status: Enrolling
Updated: 12/31/1969
Novartis
mi
from
New York, NY
Click here to add this to my saved trials
52-104 Week Off-therapy Second Extension to Study CSPP100A2365
A Multicenter, Double-blind 52 to 104 Week Off-therapy Extension Study to Evaluate the Long Term Growth and Development of Pediatric Hypertensive Patients 6 - 17 Years of Age Previously Treated With Aliskiren in Studies CSPP100A2365 and/or CSPP100A2365E1
Status: Enrolling
Updated:  12/31/1969
Novartis
mi
from
Portland, OR
52-104 Week Off-therapy Second Extension to Study CSPP100A2365
A Multicenter, Double-blind 52 to 104 Week Off-therapy Extension Study to Evaluate the Long Term Growth and Development of Pediatric Hypertensive Patients 6 - 17 Years of Age Previously Treated With Aliskiren in Studies CSPP100A2365 and/or CSPP100A2365E1
Status: Enrolling
Updated: 12/31/1969
Novartis
mi
from
Portland, OR
Click here to add this to my saved trials